Mometason Orion (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometason Orion, is a corticosteroid presented as a nasal spray for nasal administration. It is used to treat allergic rhinitis, seasonal allergic rhinitis and nasal polyps in adults and children as directed by a healthcare professional.

GNH USA supplies Mometason Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance across EU and global markets. The company ensures secure logistics and documentation for cross‑border shipments.

Mometason Orion, a nasal corticosteroid, is indicated for several upper‑respiratory inflammatory conditions.

Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea. Seasonal allergic rhinitis: provides symptom relief during pollen seasons. Nasal polyps: helps shrink polyps and improve nasal airflow.

Mometason Orion may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation - Epistaxis (nosebleed) - Headache - Throat irritation or dryness - Altered taste perception

Serious or Rare Side Effects: - Adrenal suppression with systemic exposure - Cataracts or glaucoma - Severe allergic reaction (anaphylaxis) - Fungal infection of the nasal passages

Before using Mometason Orion, consider the following precautions.

Pediatric use: follow prescriber guidance, as safety data are limited in children under two years. Active nasal infection: avoid use until infection resolved. Recent eye surgery: use with caution due to potential intra‑ocular pressure increase. Systemic corticosteroid exposure: monitor for signs of adrenal suppression. Abrupt discontinuation: taper if long‑term therapy is required. Store at room temperature: keep in original container, protect from moisture and heat.

Mometason Orion can interact with other medicines; review the following.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic exposure to mometasone. - Live nasal vaccines: concurrent use may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Azole antifungals (e.g., itraconazole): may modestly raise mometasone levels. - Macrolide antibiotics (e.g., erythromycin): potential increase in systemic effects. - Herbal St. John’s wort: may reduce corticosteroid efficacy.